Mammary-like anogenital fibroadenomas are rare entities within the wide spectrum of female genital pathology. Our paper provides an up-to-date review, by systematization of the concepts and controversies, from the origin to the development and the diagnosis of the lesion. The theories pertaining to its histogenesis incorporate its debated origin of ectopic mammary-derived lesions, of cutaneous apocrine, eccrine, sebaceous, and mammary-like anogenital glands. Although rare, both clinicians and pathologists should consider this lesion type within the differential diagnosis of anogenital pathology, regardless of the woman's age, and pathological confirmation is mandatory to exclude the possibility of other tumours, including malignancy. Immunohistochemistry may represent a useful tool in tumor characterisation and in differential diagnosis.
Introduction
Anogenital pathology comprises mainly epithelial tumours, squamous cell carcinoma representing 80% of them [1] .
Mammary-like adenomas are unusual anogenital tumors [1] . The histological origin of these lesions is controversial, including postulation of ectopic mammary-derived lesions [1] , cutaneous apocrine, eccrine, sebaceous, and mammary-like anogenital glands [2] .
The development of an accessory breast tissue is attributed to the failure of regression of milk lines remnants during embryogenesis. The accessory breast can develop anywhere along the milk line, extending from axilla to the groin [3] . An extremely rare presentation consists of a vulvar accessory breast [4] . The literature review identified mainly unilateral or bilateral location within labium majus.
Relatively recent studies have found that the tumors previously thought to be apocrine are currently considered as derived from anogenital mammary-like glands and are termed mammary-like glands adenomas [5, 6] . The locations are similar to the common distribution of mammary-like glands (labia minora, labia majora, fourchette, and clitoris) [6] .
Our review of the literature highlights the histological criteria which support the origin hypothesis within mammary-type anogenital glands versus embryological remnants and provides a synopsis of tumor specific clinical and histopathological features.
Embryological update
The anogenital adenoma diagnosis is entitled to a particular consideration due to its rarity and due to its hypothetical origin either within anogenital sweat glands, or either ectopic mammary tissue, as a result of embryogenesis anomalies [2, 3] .
A brief embryological update is useful in understanding the mechanism of development of anogenital mammary ectopic tissue.
The mammary glands are modified apocrine glands arising along the mammary ridges which appear on either side of the body, persisting only a short period. The mammary glands begin their development during the fourth week of embryogenesis and extend as two surface thickenings from the axillary to inguinal regions [7] . Remnants of these ridges can result in an arborizing network of canals, as the origin of aberrant lactiferous ducts in various anatomical locations in the form of ectopic breast tissue [7] .
Aberrant breast tissue
Aberrant mammary tissue occurs in 1-6% of the population, being more prevalent in women in axilla and in upper umbilical scars location [3, 4, 8] . Supernumerary breasts or nipples, polymastia and polythelia may develop from extramammary buds and rarely from tissue displaced from these ridges. Frequently, as a result of hormone-induced swelling, they manifest during pregnancy and lactation [3] .
Less commonly, accessory breasts appear in locations outside of the mammary ridges, such as face, posterior neck, chest, middle back, buttock, flank, hip, posterior and/or lateral thigh, shoulder, and upper extremities [3, 4] .
The ectopic breast tissue has similar hormone-induced histologic changes during puberty and pregnancy, due to stimulation of their hormonal receptors [7, 9] . The hormonal regulation can lead to the potential development of tumoral proliferations analogous to those diagnosed in normally localized mammary tissue [10] .
Historical records
A completely formed mammary gland tissue arising in the vulvar region was firstly described in a 30-years old woman, in the left labium majus, in 1872, as "mamma erratica" [1] . The tumor was located in the inner aspect of the left labium majus and was described as large as a "goose egg" and pedunculated [1] . It had been noticed at birth and showed cyclic changes. The tumor showed central erosion and elimination of a milky secretory product. The nipple was microscopically identified in the center of the eroded area [1] .
Anogenital sweat glands
The concept of vulvar lesions derived from milk lines rudiments has recently been challenged by the incidental identification of anogenital sweat glands in the interlabial sulcus [2, 5] . These are related to eccrine or apocrine glands, being composed of mammary-like ducts with a prominent basement membrane and a dense or loose stromal cuff [2, 5] .
Controversial hypothesis
The phylogenetic and ontogenetic hypotheses launched at the beginning of the last century have not been confirmed in human embryos, as mammary glands primordial do not extend beyond the axillary-pectoral region [5] . Thus, the hypotheses of development of accessory breast tissue from these anogenital sweat glands or from caudal remnants of the milk lines are dismissed and lesions such as fibroadenoma, lactating adenoma, hidradenoma papilliferum, hidrocystoma, extramammary Paget's disease, and invasive adenocarcinoma are considered as originating from mammary-like glands [5] .
Literature synopsis
A synopsis of the main characteristics exhibited by 30 well documented reports of 92 cases of mammary-type fibroepithelial vulvar neoplasms is shown in Table I, exhibiting an extremely variable age at the moment of diagnosis and surgical excision (17 to 90 years) and a large variability of the tumor size (0.7 to 40 cm).
Clinical presentation
The anogenital mass may request clinical examination due to discomfort felt by the patient or may only become noticeable if it significantly increases in size. Other reported symptoms include pruritus and bleeding [6] .
For the clinician, the differential diagnosis of a subcutaneous lump should include benign cystic lesions such as follicular or Bartholin cysts, hidradenoma papilliferum, primary neoplasms of connective and vascular tissue.
The tumors are clinically described as solid, ulcerated, or cystic [6] .
The outcome is generally good after complete surgical excision and the risk of recurrence is low, excepting phyllodes type tumours and bilateral location within the vulva [3, 9] .
Histopathologic spectrum
The microscopic examination performed on routine sections (Professor Cornelia Amalinei, 2013) reveals lesions lined by simple cuboidal epithelium (Fig. 1) and containing both epithelial and stromal components (Fig. 2) . The histological components are ducts and lobules in an abundant hyalinized stroma exhibiting focal leaf-like architecture without evident proliferation activity (Fig. 2) . The ducts are lined by a layer of epithelial cells with decapitation aspect doubled by a conspicuous layer of myoepithelial cells (Fig. 3) , without architectural or cytologic atypia.
Fibrocystic changes, lactating adenoma, intraductal papilloma, and extra-mammary Paget disease had been also reported in vulvar mammary-type tissue [6, 25, 30] . Adenocarcinoma may also arise in vulvar mammary-like glands and has to be differenti- NA -not available ated from conventional cutaneous adenocarcinoma of apocrine and eccrine origin and metastatic mammary carcinoma [8, 21, 28] . Extralesional tissue documentation may certify the development of the lesions within mammary-like glands [3, 6, 20, 25] . Due to well-circumscribed limits of the lesion and thus the "shelled out" modality of surgical removal, no documentation of the adjacent mammary-like anogenital glands is available in the majority of reported cases [3, 4] .
Immunohistochemistry contribution
Immunohistochemistry is useful in tumor characterization, as the luminal cells are generally positive for cytokeratin, estrogen receptor (ER) (Fig. 4) , progesterone receptor (PR), and gross cystic disease fluid protein (GCDFP15) ( smooth-muscle-actin (SMA) and S-100, supporting their myoepithelial nature [21] .
Furthermore, recent studies demonstrated the expression of a breast differentiation antigen (NY-BR-1) in a vulvar phyllodes tumor and in the neighboring mammary-like glands along with steroid receptors immunopositivity [7] , as a supplementary common immunophenotypical feature.
Conclusions
Although rare, we should consider mammary-like fibroadenomas within the differential diagnosis of anogenital pathology regardless of the woman's age, tumor size, and specific location. The pathological confirmation is mandatory to exclude the possibility of other tumors occurrence, including malignancy.
Further extensive histological research by assessment of the normal adjacent tissue and the development of new molecular markers may provide new evidences to consolidate the current concept of mammary-like gland anogenital adenomas origin within mammary-type anogenital glands, as one of the debated histogenetic hypotheses.
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